Africa has extraordinary genetic diversity and a significant burden of disease, but the continent still plays a relatively small role in developing the biotechnology products and treatments used around the world. South African biotech company Altera Biosciences believes that represents an opportunity.

To discuss Africa's potential in biotechnology, the investment required and why more scientific innovation should be commercialised on the continent is Alexandra Miszewski, co-founder and CEO of Altera Biosciences speaking to Mpho Sithole.

Africa has extraordinary genetic diversity and a significant burden of disease, but the continent still plays a relatively small role in developing the biotechnology products and treatments used around the world. South African biotech company Altera Biosciences believes that represents an opportunity.
To discuss Africa's potential in biotechnology, the investment required and why more scientific innovation should be commercialised on the continent is Alexandra Miszewski, co-founder and CEO of Altera Biosciences speaking to Mpho Sithole.

An English news and current affairs wrap with a fresh take on the day’s top stories, hosted by the seasoned journalist Tsepiso Makwetla.

An English news and current affairs wrap with a fresh take on the day&rsquo;s top stories, hosted by the seasoned journalist Tsepiso Makwetla.